Trial Profile
Phase I/II Open Label Evaluation of the Safety and Efficacy of Rituximab in Patients With Chronic Urticaria (The Rituximab Urticaria Study - "RUSTY")
Status:
Suspended
Phase of Trial:
Phase I/II
Latest Information Update: 04 Sep 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Urticaria
- Focus Adverse reactions
- Acronyms RUSTY
- 22 Oct 2014 New trial record